Associate Director, Non-GLP Bioanalysis
WuXi AppTec
Shanghai, Shanghai, China (People's Republic)
Dr. Li Qu graduated from Fudan University. She joined DMPK of WuXi AppTec Co.,Ltd in November 2021. She’s in New Capability Group of the Bioanalysis Team. As associate director, she’s responsible for the construction of large molecule bioanalysis platforms. Now she is focus on ADCs, fusion protein, chiral drugs and covalent inhibitor screening area. She demonstrated extensive experience in large molecular bioanalysis Area.
Disclosure information not submitted.
Integrated Bioanalysis and Biotransformation Strategies for Antibody-Drug Conjugates
Monday, October 21, 2024
11:00 AM – 12:00 PM MT